Table 3 GRADE evidence profile of PFN versus DHS for patients with trochanteric fracture included in randomized clinical trials.
Outcome | Number of trials (≤ 12 total) | No. of patients (N ≤ 1889 total) | Follow-up, months (min; max) | Serious risk of bias? | Inconsistency: I2 (%) | Serious indirectness? | Serious imprecision? | Serious risk of reporting bias? | Effect size (95%CI) | Quality of the evidence |
|---|---|---|---|---|---|---|---|---|---|---|
Operative time | 11 | 1667 | Intraoperation | Yes | Yes(98%) | No | Yes | No | − 9.49(− 18.74 to 0.25) | Very low |
Blood loss | 8 | 781 | Intraoperation | Yes | Yes (95%) | No | No | No | − 158.20 (− 203.05 to − 113.34) | Low |
Fluoroscopy time | 7 | 1371 | Intraoperation | Yes | Yes (99%) | No | Yes | No | 0.43 (0.18 to 0.68) | Low |
Closed reduction | 5 | 1042 | Post-operation | Yes | No (52%) | No | No | No | 1.02 (0.99 to 1.05) | Moderate |
Non-Union | 5 | 1091 | 12;12 | Yes | No (0%) | No | No | No | 0.93(0.44 to 1.96) | Moderate |
Implant Failure | 10 | 1749 | 4;24 | Yes | No (32%) | No | No | No | 0.78 (0.35 to 1.75)) | Moderate |
Revision | 4 | 886 | 12;12 | Yes | No (44%) | No | No | No | 0.84 (0.22 to 3.15) | Moderate |